OTCMKTS:PDDPF

Medexus Pharmaceuticals (PDDPF) Stock Price, News & Analysis

$2.14
0.00 (0.00%)
(As of 08/4/2023)
Today's Range
$2.11
$2.42
50-Day Range
$2.14
$2.14
52-Week Range
$1.70
$3.99
Volume
39,966 shs
Average Volume
4,355 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PDDPF stock logo

About Medexus Pharmaceuticals Stock (OTCMKTS:PDDPF)

Medexus Pharmaceuticals, Inc. operates as a pharmaceutical company. It provide healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The company products include Rasuvo, Metoject and Rupall. Medexus was founded by Sylvain Chretien in January 2008 and is headquartered in Verdun, Canada.

PDDPF Stock Price History

PDDPF Stock News Headlines

Medexus Pharmaceuticals Inc MEDXF
Missed NVDA? Buy this AI stock NOW
After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.
Medexus Pharmaceuticals Inc MDP
Missed NVDA? Buy this AI stock NOW
After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.
Stifel Nicolaus Upgrades Medexus Pharmaceuticals Inc (MDP) to Buy
Morning News Call - Canada, June 20
See More Headlines
Receive PDDPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:PDDPF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Kenneth d’Entremont
    Chief Executive Officer & Director
  • Roland Boivin
    Chief Financial Officer
  • Michael Pine
    Senior VP-Business Development & Strategy
  • Richard Labelle
    Vice President-Marketing & Sales

PDDPF Stock Analysis - Frequently Asked Questions

How have PDDPF shares performed in 2024?

Medexus Pharmaceuticals' stock was trading at $2.14 at the beginning of the year. Since then, PDDPF stock has increased by 0.0% and is now trading at $2.14.
View the best growth stocks for 2024 here
.

How do I buy shares of Medexus Pharmaceuticals?

Shares of PDDPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PDDPF) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners